ClinicalTrials.Veeva

Menu

Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease (LACME)

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

Alzheimer's Disease

Treatments

Behavioral: Painting sessions.
Behavioral: Singing sessions.

Study type

Interventional

Funder types

Other

Identifiers

NCT02670993
1508071
2015-A01404-45 (Other Identifier)

Details and patient eligibility

About

Alzheimer Disease (AD), characterized by cognitive and psycho-behavioral troubles, concerns essentially 65 years old and older patients. Antalgic and psychotropic treatments have adverse effects in old people, and have to be used carefully. To improve the pain support and limit the drug consumption, it is possible to perform therapies without drugs. Among them, musical intervention represents an interesting complementary support, to deal with physical and moral pain in AD.

Full description

Alzheimer Disease (AD), characterized by cognitive and psycho-behavioral troubles, concerns essentially 65 years old and older patients. At this age, comorbidities are frequent and numerous, and often linked to pain. The prevalence is comprised between 40 and 85% according to different studies. Antalgic and psychotropic treatments have adverse effects in old people, and have to be used carefully. To improve the pain support and limit the drug consumption, it is possible to perform therapies without drugs. Among them, musical intervention represents an interesting complementary support, to deal with physical and moral pain in AD.

The primary outcome is to evaluate the singing support on physical pain, by comparison with a control activity : "painting session".

Enrollment

59 patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients 60 years old and older, fulfilling the diagnostic criteria for Alzheimer's disease to a mild dementia stage, or mild cognitive impairment
  • Delay of at least one month between the diagnosis and the early work sessions
  • If use of psychotropic drugs, they must be stabilized for 3 month
  • If analgesics consumption level 2 or 3 they must be stabilized for 1 month
  • With a score greater than or equal to 22 on the simplified visual scale (EVS) pain.
  • Visual capabilities , auditory and oral or written expression in French language sufficient for conducting clinical and neuropsychological evaluations;
  • MMSE > 20
  • Patient affiliated or entitled to a social security scheme

Exclusion criteria

  • Patient with a different etiology of cognitive disorder that of Alzheimer's disease
  • Patients with severe disease, progressive or unstable nature which may interfere with the evaluation variables
  • Patient with blindness or deafness could compromise its assessment
  • Patient under guardianship

Trial design

59 participants in 2 patient groups

Control group : Singing sessions.
Experimental group
Description:
Patients will participate to singing working sessions. They will continue to take their usual treatments during the study period.
Treatment:
Behavioral: Singing sessions.
Control group : Painting sessions.
Active Comparator group
Description:
Patients will continue to participate to painting work sessions, and to take their usual treatments during the study.
Treatment:
Behavioral: Painting sessions.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems